Intelligent Bio Solutions... (INBS)
Intelligent Bio Solutions Statistics
Share Statistics
Intelligent Bio Solutions has 6.78M shares outstanding. The number of shares has increased by 54.23% in one year.
| Shares Outstanding | 6.78M |
| Shares Change (YoY) | 54.23% |
| Shares Change (QoQ) | 3.22% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 6.66M |
| Failed to Deliver (FTD) Shares | 26.11K |
| FTD / Avg. Volume | 12.22% |
Short Selling Information
The latest short interest is 369.43K, so 7.69% of the outstanding shares have been sold short.
| Short Interest | 369.43K |
| Short % of Shares Out | 7.69% |
| Short % of Float | 7.85% |
| Short Ratio (days to cover) | 1.25 |
Valuation Ratios
The PE ratio is -0.57 and the forward PE ratio is 4.11. Intelligent Bio Solutions's PEG ratio is 0.01.
| PE Ratio | -0.57 |
| Forward PE | 4.11 |
| PS Ratio | 1.87 |
| Forward PS | 0.7 |
| PB Ratio | 0.7 |
| P/FCF Ratio | -0.6 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Intelligent Bio Solutions Inc. has an Enterprise Value (EV) of 33.32M.
| EV / Earnings | -3.28 |
| EV / Sales | 10.71 |
| EV / EBITDA | -3.78 |
| EV / EBIT | -3.24 |
| EV / FCF | -3.4 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.1.
| Current Ratio | 1.57 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.1 |
| Total Debt / Capitalization | 9.47 |
| Cash Flow / Debt | -10.98 |
| Interest Coverage | -61.52 |
Financial Efficiency
Return on equity (ROE) is -1.22% and return on capital (ROIC) is -113.57%.
| Return on Equity (ROE) | -1.22% |
| Return on Assets (ROA) | -0.74% |
| Return on Capital (ROIC) | -113.57% |
| Revenue Per Employee | $62,235.62 |
| Profits Per Employee | $-203,135.18 |
| Employee Count | 50 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -63.27% in the last 52 weeks. The beta is 4.64, so Intelligent Bio Solutions's price volatility has been higher than the market average.
| Beta | 4.64 |
| 52-Week Price Change | -63.27% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 32.29 |
| Average Volume (20 Days) | 213.68K |
Income Statement
In the last 12 months, Intelligent Bio Solutions had revenue of 3.11M and earned -10.16M in profits. Earnings per share was -6.38.
| Revenue | 3.11M |
| Gross Profit | 1.43M |
| Operating Income | -10.28M |
| Net Income | -10.16M |
| EBITDA | -8.81M |
| EBIT | -10.28M |
| Earnings Per Share (EPS) | -6.38 |
Balance Sheet
The company has 6.3M in cash and 871.44K in debt, giving a net cash position of 5.43M.
| Cash & Cash Equivalents | 6.3M |
| Total Debt | 871.44K |
| Net Cash | 5.43M |
| Retained Earnings | -51.96M |
| Total Assets | 8.68M |
| Working Capital | -341.24K |
Cash Flow
In the last 12 months, operating cash flow was -9.57M and capital expenditures -221.43K, giving a free cash flow of -9.79M.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -221.43K |
| Free Cash Flow | -9.79M |
| FCF Per Share | -3.07 |
Margins
Gross margin is 45.81%, with operating and profit margins of -330.46% and -326.4%.
| Gross Margin | 45.81% |
| Operating Margin | -330.46% |
| Pretax Margin | -327.5% |
| Profit Margin | -326.4% |
| EBITDA Margin | -283.14% |
| EBIT Margin | -330.46% |
| FCF Margin | -314.71% |
Dividends & Yields
INBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -411.61% |
| FCF Yield | -93.14% |
Analyst Forecast
Currently there are no analyst rating for INBS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 29, 2024. It was a backward split with a ratio of 1:12.
| Last Split Date | Jan 29, 2024 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -11.27 |
| Piotroski F-Score | 4 |